What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
The scientist’s investigation covers issues in Surgery, Pancreatic cancer, Internal medicine, Pancreatic disease and Pancreatectomy.
The concepts of his Surgery study are interwoven with issues in Pancreatic surgery and Pancreatic fistula.
His Pancreatic cancer study frequently links to adjacent areas such as Radiation therapy.
As part of one scientific family, Helmut Friess deals mainly with the area of Internal medicine, narrowing it down to issues related to the Gastroenterology, and often Fluorouracil, Chemotherapy and Combination chemotherapy.
His Pancreatic disease study is concerned with Pancreas in general.
His research in Pancreatectomy intersects with topics in Preoperative care, Acute pancreatitis, General surgery, Necrosis and Pancreatitis.
His most cited work include:
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer (1989 citations)
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula : 11 Years After (1157 citations)
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages (961 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Pancreatic cancer, Surgery, Gastroenterology and Pancreatic disease.
His study in the fields of Radiation therapy and Chemotherapy under the domain of Internal medicine overlaps with other disciplines such as Amylase.
His Pancreatic cancer study combines topics from a wide range of disciplines, such as Cancer research, Carcinoma, Pathology and Oncology.
His Surgery research is multidisciplinary, incorporating elements of Cancer and Pancreatic surgery.
His study in Gastroenterology is interdisciplinary in nature, drawing from both Necrosis and Pancreatic juice.
His Pancreatic disease study incorporates themes from Prospective cohort study, Pancreatitis and Adenocarcinoma.
He most often published in these fields:
- Internal medicine (55.74%)
- Pancreatic cancer (50.82%)
- Surgery (36.07%)
What were the highlights of his more recent work (between 2015-2020)?
- Surgery (36.07%)
- Pancreaticoduodenectomy (11.48%)
- Internal medicine (55.74%)
In recent papers he was focusing on the following fields of study:
Helmut Friess spends much of his time researching Surgery, Pancreaticoduodenectomy, Internal medicine, Gastroenterology and Retrospective cohort study.
The Surgery study combines topics in areas such as Pancreatic surgery, General surgery and Intensive care medicine.
His studies deal with areas such as Pancreatic head, Fistula and Pancreatitis as well as Pancreaticoduodenectomy.
His Internal medicine research incorporates themes from Antibiotic resistance and Immunology.
His Retrospective cohort study research includes themes of Survival rate and Gemcitabine, Chemotherapy.
His Survival rate study combines topics in areas such as Concordance, Pancreatectomy and Carcinoma.
Between 2015 and 2020, his most popular works were:
- The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula : 11 Years After (1157 citations)
- Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. (43 citations)
- A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy. (23 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His primary areas of study are Survival rate, Retrospective cohort study, Pancreatic fistula, Surgery and Gemcitabine.
His studies in Survival rate integrate themes in fields like Gastroenterology and Pancreatectomy.
His Retrospective cohort study study typically links adjacent topics like Pancreatic cancer.
His research ties Normal serum and Surgery together.
His research integrates issues of Concordance and Carcinoma in his study of Gemcitabine.
While working on this project, Helmut Friess studies both Carcinoma and Algorithm.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
